2 ms·
"...An international study has found that patients given trastuzumab deruxtecan had an estimated overall survival rate of 94% after 12 months..." "Trastuzumab
by belter 5y ago
"...An international study has found that patients given trastuzumab deruxtecan had an estimated overall survival rate of 94% after 12 months..."
"Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer":
https://www.nejm.org/doi/full/10.1056/nejmoa1914510 https://www.nejm.org/doi/full/10.1056/nejmoa1914510